We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+7.27%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$1.85B
AUM Growth
+$639M
Cap. Flow
+$551M
Cap. Flow %
29.85%
Top 10 Hldgs %
16.26%
Holding
807
New
369
Increased
263
Reduced
92
Closed
81

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$17.6M
2
XLNX
Xilinx Inc
XLNX
+$12.8M
3
IPGP icon
IPG Photonics
IPGP
+$12.6M
4
RAVN
Raven Industries Inc
RAVN
+$12.4M
5
CDNS icon
Cadence Design Systems
CDNS
+$11.9M

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$3.34M
2
HUN icon
Huntsman Corp
HUN
+$2.99M
3
STT icon
State Street
STT
+$2.9M
4
PFG icon
Principal Financial Group
PFG
+$2.84M
5
LPNT
LifePoint Health, Inc.
LPNT
+$2.76M

Sector Composition

Rank Sector Weight
1 Technology 22.97%
2 Industrials 14.16%
3 Healthcare 11.61%
4 Financials 7.62%
5 Consumer Discretionary 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSGS
301
DELISTED
CSG Systems International
CSGS
$1.63M 0.09%
40,529
-357
-0.9% -$14.1K
GOOGL icon
302
Alphabet (Google) Class A
GOOGL
$4.38T
$1.6M 0.09%
32,960
+20,360
+162% +$966K
RDC
303
DELISTED
Rowan Companies Plc
RDC
$1.59M 0.09%
123,549
-1,383
-1% -$14.8K
VZ icon
304
Verizon
VZ
$195B
$1.57M 0.09%
+31,747
New +$1.49M
TWTR
305
DELISTED
Twitter, Inc.
TWTR
$1.57M 0.09%
+93,135
New +$1.63M
PRGO icon
306
Perrigo
PRGO
$1.74B
$1.56M 0.08%
18,454
+14,492
+366% +$1.13M
ED icon
307
Consolidated Edison
ED
$40.2B
$1.56M 0.08%
+19,341
New +$1.6M
CTMX icon
308
CytomX Therapeutics
CTMX
$734M
$1.55M 0.08%
85,539
+2,147
+3% +$33.5K
ATRA icon
309
Atara Biotherapeutics
ATRA
$74.3M
$1.55M 0.08%
3,737
+113
+3% +$42.6K
AMGN icon
310
Amgen
AMGN
$219B
$1.53M 0.08%
8,210
+454
+6% +$80.4K
CMG icon
311
Chipotle Mexican Grill
CMG
$42.7B
$1.53M 0.08%
+248,700
New +$1.68M
DK icon
312
Delek US
DK
$3.59B
$1.53M 0.08%
+57,214
New +$1.43M
DG icon
313
Dollar General
DG
$28.1B
$1.52M 0.08%
+18,755
New +$1.41M
EA
314
DELISTED
Electronic Arts
EA
$1.51M 0.08%
+12,815
New +$1.48M
AGEN
315
Agenus
AGEN
$312M
$1.49M 0.08%
17,218
+521
+3% +$42.2K
BLUE
316
DELISTED
bluebird bio
BLUE
$1.48M 0.08%
831
+45
+6% +$62.9K
CLX icon
317
Clorox
CLX
$12.8B
$1.48M 0.08%
+11,199
New +$1.5M
LHO
318
DELISTED
LaSalle Hotel Properties
LHO
$1.47M 0.08%
50,557
-30,595
-38% -$885K
CLLS
319
Cellectis
CLLS
$271M
$1.47M 0.08%
51,542
+1,561
+3% +$40.4K
IOVA icon
320
Iovance Biotherapeutics
IOVA
$2.77B
$1.44M 0.08%
185,628
– –
CLDX icon
321
Celldex Therapeutics
CLDX
$3.26B
$1.42M 0.08%
33,001
+1,000
+3% +$37.5K
KO icon
322
Coca-Cola
KO
$374B
$1.4M 0.08%
+31,028
New +$1.41M
KDP icon
323
Keurig Dr Pepper
KDP
$41.3B
$1.38M 0.07%
+15,534
New +$1.41M
IBM icon
324
IBM
IBM
$220B
$1.33M 0.07%
+9,575
New +$1.33M
JNJ icon
325
Johnson & Johnson
JNJ
$619B
$1.32M 0.07%
+10,191
New +$1.35M
11 12
13
14 15

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return

Vident Investment Advisory's Q3 2017 Portfolio in Review

As of Q3 2017, Vident Investment Advisory held 807 positions worth $1.85B, up 53% from $1.21B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Vident Investment Advisory deployed $551M of net new capital in Q3 2017, opening 369 new positions and adding to 263 existing holdings. Its largest new stake was Xilinx Inc: 195,171 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $3.34M trimmed.

  • Vident Investment Advisory's largest Q3 2017 buy was Xilinx Inc: 195,171 shares worth $13.8M.
  • Vident Investment Advisory added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $17.6M increase.
  • Vident Investment Advisory's biggest Q3 2017 reduction was Berkshire Hathaway Class B, cutting an estimated $3.34M.
  • Vident Investment Advisory fully exited Huntsman Corp in Q3 2017, selling an estimated $2.99M.
  • Vident Investment Advisory's ten largest holdings make up 16% of its $1.85B portfolio in Q3 2017.
  • Vident Investment Advisory opened 369 new positions and closed 81 in Q3 2017.
  • Vident Investment Advisory's portfolio value rose 53% quarter-over-quarter to $1.85B.

Based on Vident Investment Advisory's 13F filing for Q3 2017, filed 14 Nov 2017.